Literature DB >> 16565846

Loss of neuronal integrity: a cause of hypometabolism in patients with traumatic brain injury without MRI abnormality in the chronic stage.

Tohru Shiga1, Katsunori Ikoma, Chietsugu Katoh, Hirotaka Isoyama, Tetsuaki Matsuyama, Yuji Kuge, Hiroyuki Kageyama, Tomoya Kohno, Satoshi Terae, Nagara Tamaki.   

Abstract

PURPOSE: Traumatic brain injury (TBI) causes brain dysfunction in many patients. However, some patients have severe brain dysfunction but display no abnormalities on magnetic resonance imaging (MRI). There have been some reports of hypometabolism even in such patients. The purpose of this study was to investigate the relationship between metabolic abnormality and loss of neuronal integrity in TBI patients with some symptoms but without MRI abnormalities.
METHODS: The study population comprised ten patients with TBI and ten normal volunteers. All of the patients were examined at least 1 year after the injury. ( 15)O-labelled gas PET and [(11)C]flumazenil (FMZ) positron emission tomography (PET) were carried out. The cerebral metabolic rate of oxygen (CMRO(2)) and binding potential (BP) images of FMZ were calculated. Axial T2WI, T2*WI and FLAIR images were obtained. Coronal images were added in some cases.
RESULTS: All of the patients had normal MRI findings, and all showed areas with abnormally low CMRO(2). Low uptake on BP images was observed in six patients (60%). No lesions that showed low uptake on BP images were without low CMRO(2). On the other hand, there were 14 lesions with low CMRO(2) but without BP abnormalities.
CONCLUSION: These results indicate that there are metabolic abnormalities in TBI patients with some symptoms after brain injury but without abnormalities on MRI. Some of the hypometabolic lesions showed low BP, indicating a loss of neuronal integrity. Thus, FMZ PET may have potential to distinguish hypometabolism caused by neuronal loss from that caused by other factors.

Entities:  

Mesh:

Year:  2006        PMID: 16565846     DOI: 10.1007/s00259-005-0033-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  28 in total

1.  Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF.

Authors:  M Ohyama; M Senda; K Ishiwata; S Kitamura; M Mishina; K Ishii; H Toyama; K Oda; Y Katayama
Journal:  Ann Nucl Med       Date:  1999-10       Impact factor: 2.668

2.  [11C]Flumazenil PET in patients with epilepsy with dual pathology.

Authors:  C Juhász; F Nagy; O Muzik; C Watson; J Shah; H T Chugani
Journal:  Epilepsia       Date:  1999-05       Impact factor: 5.864

3.  [Evaluation of 123I-iomazenil SPECT in patients with ischemic cerebrovascular disease: comparative study with 123I-IMP SPECT].

Authors:  H Moriwaki; M Matsumoto; K Hashikawa; N Oku; M Ishida; Y Seike; M Fujita; K Fukuchi; Y Watanabe; H Terakawa; T Uehara; T Nishimura
Journal:  Kaku Igaku       Date:  1996-06

4.  Delayed hemispheric neuronal loss in severely head-injured patients.

Authors:  T Shiozaki; H Akai; M Taneda; T Hayakata; M Aoki; J Oda; H Tanaka; A Hiraide; T Shimazu; H Sugimoto
Journal:  J Neurotrauma       Date:  2001-07       Impact factor: 5.269

5.  Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke.

Authors:  W D Heiss; M Grond; A Thiel; M Ghaemi; J Sobesky; J Rudolf; B Bauer; K Wienhard
Journal:  Stroke       Date:  1998-02       Impact factor: 7.914

6.  Identification by positron emission tomography of neuronal loss in acute vegetative state.

Authors:  J Rudolf; J Sobesky; M Grond; W D Heiss
Journal:  Lancet       Date:  2000-01-08       Impact factor: 79.321

7.  Metabolic changes in pericontusional oedematous areas in mild head injury evaluated by 1H MRS.

Authors:  B C Son; C K Park; B G Choi; E N Kim; B Y Choe; K S Lee; M C Kim; J K Kang
Journal:  Acta Neurochir Suppl       Date:  2000

8.  Changes in gamma-aminobutyric acid and somatostatin in epileptic cortex associated with low-grade gliomas.

Authors:  M M Haglund; M S Berger; D D Kunkel; J E Franck; S Ghatan; G A Ojemann
Journal:  J Neurosurg       Date:  1992-08       Impact factor: 5.115

9.  Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases.

Authors:  Satoshi Kuroda; Tohru Shiga; Tatsuya Ishikawa; Kiyohiro Houkin; Takuhito Narita; Chietsugu Katoh; Nagara Tamaki; Yoshinobu Iwasaki
Journal:  J Nucl Med       Date:  2004-06       Impact factor: 10.057

10.  Characterisation of [123I]iomazenil distribution in a rat model of focal cerebral ischaemia in relation to histopathological findings.

Authors:  Tomohito Kaji; Yuji Kuge; Chiaki Yokota; Masafumi Tagaya; Hiroyasu Inoue; Tohru Shiga; Kazuo Minematsu; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-08       Impact factor: 9.236

View more
  12 in total

Review 1.  Imaging the role of GABA in movement disorders.

Authors:  Henning Boecker
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 5.081

Review 2.  A Review of the Effectiveness of Neuroimaging Modalities for the Detection of Traumatic Brain Injury.

Authors:  Franck Amyot; David B Arciniegas; Michael P Brazaitis; Kenneth C Curley; Ramon Diaz-Arrastia; Amir Gandjbakhche; Peter Herscovitch; Sidney R Hinds; Geoffrey T Manley; Anthony Pacifico; Alexander Razumovsky; Jason Riley; Wanda Salzer; Robert Shih; James G Smirniotopoulos; Derek Stocker
Journal:  J Neurotrauma       Date:  2015-09-30       Impact factor: 5.269

3.  Recovered neuronal viability revealed by Iodine-123-iomazenil SPECT following traumatic brain injury.

Authors:  Hiroyasu Koizumi; Hirosuke Fujisawa; Tetsu Kurokawa; Eiichi Suehiro; Hideyuki Iwanaga; Jyoji Nakagawara; Michiyasu Suzuki
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-04       Impact factor: 6.200

4.  Glycolytic inhibitor 2-deoxyglucose prevents cortical hyperexcitability after traumatic brain injury.

Authors:  Jenny B Koenig; David Cantu; Cho Low; Mary Sommer; Farzad Noubary; Danielle Croker; Michael Whalen; Dong Kong; Chris G Dulla
Journal:  JCI Insight       Date:  2019-04-30

5.  Parcellating the neuroanatomical basis of impaired decision-making in traumatic brain injury.

Authors:  Virginia F J Newcombe; Joanne G Outtrim; Doris A Chatfield; Anne Manktelow; Peter J Hutchinson; Jonathan P Coles; Guy B Williams; Barbara J Sahakian; David K Menon
Journal:  Brain       Date:  2011-02-09       Impact factor: 13.501

6.  Longitudinal alterations in gamma-aminobutyric acid (GABAA) receptor availability over ∼ 1 year following traumatic brain injury.

Authors:  Y Kang; K Jamison; A Jaywant; K Dams-O'Connor; N Kim; N A Karakatsanis; T Butler; N D Schiff; A Kuceyeski; S A Shah
Journal:  Brain Commun       Date:  2022-06-15

7.  Characterization of Brain Dysfunction Induced by Bacterial Lipopeptides That Alter Neuronal Activity and Network in Rodent Brains.

Authors:  Kwang-Min Kim; Alsu I Zamaleeva; Youn Woo Lee; M Rafiuddin Ahmed; Eunkyung Kim; Hye-Ryeon Lee; Venkata Raveendra Pothineni; Juan Tao; Siyeon Rhee; Mithya Jayakumar; Mohammed Inayathullah; Senthilkumar Sivanesan; Kristy Red-Horse; Theo D Palmer; Jon Park; Daniel V Madison; Ho-Young Lee; Jayakumar Rajadas
Journal:  J Neurosci       Date:  2018-10-31       Impact factor: 6.167

8.  I-123 iomazenil single photon emission computed tomography for detecting loss of neuronal integrity in patients with traumatic brain injury.

Authors:  Kagari Abiko; Katsunori Ikoma; Tohru Shiga; Chietsugu Katoh; Kenji Hirata; Yuji Kuge; Kentaro Kobayashi; Nagara Tamaki
Journal:  EJNMMI Res       Date:  2017-03-23       Impact factor: 3.138

9.  On the detection of cerebral metabolic depression in experimental traumatic brain injury using Chemical Exchange Saturation Transfer (CEST)-weighted MRI.

Authors:  Tsang-Wei Tu; Wael G Ibrahim; Neekita Jikaria; Jeeva P Munasinghe; Jaclyn A Witko; Dima A Hammoud; Joseph A Frank
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

Review 10.  Dysregulated Glucose Metabolism as a Therapeutic Target to Reduce Post-traumatic Epilepsy.

Authors:  Jenny B Koenig; Chris G Dulla
Journal:  Front Cell Neurosci       Date:  2018-10-16       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.